Pioneer Natural Resources (NASDAQ: PXD) reviewed 10-15-2020 Market Cap: $16.17 Billion (USD) Share Price: $92.22 (USD) Stock chart: https://www.investing.com/equities/pioneer-natural-resources-chart Shares outstanding: 175,378,954 Cash & cash equivalents: $180 Million as of 30 Jun 2020 Debt: $2.05 Billion as of 30 Jun 2020 Insiders: Low Institutional: 1017 holders hold approx. 95% Website:
Compass Pathways (NASDAQ: CMPS) reviewed 10-15-2020 Market Cap: $1.45 Billion (USD) Share Price: $37.96 (USD) Shares outstanding: 38.32 M Float is just 7.5 M shares Cash & cash equivalents: $1.76 (USD) /share Debt: large convertible notes that reportedly considerably diluted the pre-IPO shares Operations: 3 months ended Mar 2020 reported
TCR2 Therapeutics (NASDAQ: TCRR) reviewed 10-15-2020 Market Cap: $689 Million (USD) Share Price: $20.70 (USD) Shares outstanding: 33,344,021 as of 3 Aug 2020 Cash & cash equivalents: $49.7 M (USD) as of 30 Jun 2020 Debt: None. Company funds via sales of common and preferred stock Insiders: Own 5.6% Institutional:
VIR Biotechnology Inc (NASDAQ: VIR) reviewed 10-15-2020 Market Cap: $5.0 Billion (USD) Share Price: $41.26 (USD) Shares outstanding: 117,727,086 at 30 Jun 2020 Cash & cash equivalents: $371.78 Million (USD) at 30 Jun 2020 Debt: Nil. [Net Liabilities stated as $108 Million (USD) at 30 Jun 2020] Insiders: Own 14.5%
Fate Therapeutics (NASDAQ: FATE) reviewed 10-14-2020 Market Cap: $4.1 Billion (USD) Share Price: $46.96 (USD) Shares outstanding: 86,802,162 Cash & cash equivalents: $433 Million (USD) at 30 Jun 2020 Debt: None stated on the balance sheet Insiders: 2% Institutional: 221 holders own 96% of the float Website: fatetherapeutics.com Investor Presentations:
Editas Medicine (NASDAQ: EDIT) reviewed 10-14-2020 Market Cap: $2.0 Billion (USD) Share Price: $32.16 (USD) Shares outstanding: 62,103,649 Cash & cash equivalents: $485.8 M (USD) as of 30 Jun 2020 Debt: None stated on the balance sheet Insiders: 2.4% Institutional: 291 holders own approx. 76% of the float Website: editasmedicine.com
BioNTech SE (NASDAQ: BNTX) reviewed 10-14-2020 Market Cap: $20.2 Billion (USD) Share Price: $86.86 (USD) Shares outstanding: 232,304,000 Cash & cash equivalents: $519 M (Euro) at 30 June 2020 Debt: $19.45 M (Euro) via Deutsche Bank AG Insiders: 1.26% Institutional: 36 holders own approx. 4% of the float Website: biontech.de
Wallbridge Mining (TSX: WM) (OTC: WLBMF) reviewed 10-14-2020 Market Cap: $422 Million (USD) Share Price: $0.72 (USD) Shares outstanding: 586,997,997 at 31 Dec 2019 Cash: $42.5 Million (USD) at 30 Jun 2020 Debt: Nil as of 30 Jun 2020 Current operations: Exploration & Drilling Insider holdings: 35%. Institutional: 7 holders
Novavax (NASDAQ: NVAX) reviewed 10-14-2020 Market Cap: $7.23 Billion (USD) Share Price: $118.00 (USD) Shares outstanding: 61,262,632 as of 30 Jun 2020 Cash & cash equivalents: $424,395 M (USD) as of 30 Jun 2020 Debt: $323,321 M (USD) via Convertible notes Insiders: Low Institutional: 36 holders own approx. 14%
Vaxart Inc. (NASDAQ: VXRT) reviewed 10-13-2020 Market Cap: 737.4 Million (USD) Share Price: $7.67 (USD) Shares outstanding: 96,140,166 at 30 Jun 2020 Cash & cash equivalents: $ 44.4 M (USD) at 30 Jun 2020 Debt: Nil Insiders: Low, 1.2% Institutional: 36 hold ~37% of float Website: vaxart.com Investor Presentations:
Input your search keywords and press Enter.
